MS Patients Continue to Gain Function and Show Improvement With the International Society for Stem Cell Research’s Annual Meeting as his backdrop, Dr. Saud A. Sadiq delivered more promising results from Tisch MS Research Center of New York’s (Tisch MSRCNY) FDA-approved Phase I stem cell trial. The...
Interim Results Indicate Positive Efficacy Trends in FDA-Approved Phase I Clinical Stem Cell Trial For Patients with Multiple Sclerosis New York, NY - April 23, 2015 - Tisch MS Research Center of New York (Tisch MSRCNY) today announced encouraging preliminary results from its FDA-approved Phase I...
We are currently the only center in the United States that is conducting an FDA approved clinical trial using stem cells in patients with MS. The goal of the Phase I trial is to determine whether or not the therapy is safe and effective. We hope that this will lead to additional future trials and...
Congratulations to Dr. Saud A. Sadiq who has been recognized in Castle Connolly's " America's Top Doctors " 14th ed. and "Top Doctors: New York Metro Area" 18th ed. The mission of Castle Connolly Medical Ltd. is to help consumers find the best healthcare. To this end, they publish a variety of...